MAPK8 and neoplasm: Here, we report that activated human CD8+ T cells express GITR and that its expression may be regulated by the JNK pathway, which may have some further implication in translational research, like tumor immunity and inflammatory diseases, where CD8+ T cells are one of the key effector cells.